This week, the Station X team will be in attendance at the annual Molecular Med TriCon in San Francisco.  This year’s meeting will bring together more than 3,000 professionals from research, clinical and biopharmaceutical organizations to discuss the latest advances in molecular discovery and its application in diagnostics and drug discovery.

From our base of operations in the Exhibit Hall (Stand #8), we are looking forward to speaking with attendees about how GenePool, our cloud-based enterprise genome management system, is helping bridge the gap from basic research to clinical application.  

Translational medicine today is being applied mostly for discovery, and as clinical experience grows there is a need for technologies that offer insight with the data to support it. GenePool is serving this need. 

GenePool brings an entire ecosystem of high-end data computing, storage, analytics, bioinformatics pipelines, visualizations, biomedical knowledge/annotations, genomics assays, and phenotypic/clinical metadata to the fingertips of clinical and translational researchers for a powerful data mining and collaboration solution.

GenePool was designed with experts in biomarker discovery, and includes as standard the key statistical analyses they use. Added to this are powerful filtering options, novel interactive visualizations and rich and up-to-date annotations. Data and results can be saved and shared with colleagues and collaborators, greatly accelerating time-to-results.

Through an open API and industry-standard technologies, Station X offers the most flexible and customizable solution to connect key stakeholders and streamline the pathway from raw data to insights.

GenePool integrates with existing LIMS systems and leading third-party data storage and management platforms including Amazon Web Services, DNAnexus, Google Cloud Platform, Illumina BaseSpace, Microsoft Azure and Seven Bridges Genomics, among others. 

Stop by our booth (#8) for a demo or email us at  if you’d like to meet during the meeting.